We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.
- Authors
Warren, Mark L.; Chaykin, Louis B.; Jabbour, Serge; Sheikh-Ali, Mae; Hansen, Charlotte T.; Nielsen, Thor S. S.; Norwood, Paul
- Abstract
The article discusses crossover trial comparison of Insulin Degludec 200 units/mL which is collaborated with lower injection frequency and Insulin Glargine 100 units/mL in Type 2 diabetes patients. It is suggested that patients with type 2 diabetes require high basal insulin. The design of the trial, statistical analysis, and its treatments are also discussed.
- Subjects
UNITED States; BLOOD sugar analysis; TREATMENT effectiveness; CONFIDENCE intervals; PEOPLE with diabetes; GLYCOSYLATED hemoglobin; INSULIN derivatives; TYPE 2 diabetes; HEALTH outcome assessment; RESEARCH funding; T-test (Statistics); MULTIPLE regression analysis; RANDOMIZED controlled trials; DATA analysis software; STATISTICAL models; DESCRIPTIVE statistics; EVALUATION; THERAPEUTICS
- Publication
Clinical Diabetes, 2017, Vol 35, Issue 2, p90
- ISSN
0891-8929
- Publication type
Article
- DOI
10.2337/cd15-0058